Tablet placebo for aficamten 5mg tablet, Aficamten
CY 6033
Phase 3 small_molecule active
Quick answer
Tablet placebo for aficamten 5mg tablet, Aficamten for SYMPTOMATIC NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY is a Phase 3 program (small_molecule) at Cytokinetics (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cytokinetics (Ireland) Limited
- Indication
- SYMPTOMATIC NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active